Biodistribution and lymph node retention of polysaccharide-based immunostimulating nanocapsules

Vaccine

Volumn 32, Issue 15, 2014, Pages 1685-1692

  Vicente, Sara ^a,b,e   Goins, Beth A ^c   Sanchez, Alejandro ^b,d   Alonso, María J ^a,b,d   Phillips, William T ^c  

^a Universidade de Santiago de Compostela and Instituto de Investigación Sanitaria de Santiago de Compostela   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Santiago University Clinical Hospital   (Spain)

^e SANOFI   (France)

Author keywords

Biodistribution; Chitosan; Imaging; Lymph node; Nanocarrier; Nanovaccine

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IMMUNOLOGICAL ADJUVANT; IMMUNOSTIMULATING AGENT; INDIUM 111; NANOCAPSULE; POLYSACCHARIDE; SODIUM CHLORIDE; TECHNETIUM 99M;

ANALYSIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MONITORING; DRUG RETENTION; GAMMA SCINTIGRAPHY; IMAGING; IMMUNOPOTENTIATION; INCUBATION TIME; ISOTOPE LABELING; LYMPH FLOW; LYMPH NODE; LYMPHATIC SYSTEM; MALE; NEW ZEALAND WHITE (RABBIT); NONHUMAN; POPLITEAL LYMPH NODE; PRIORITY JOURNAL; RADIOACTIVITY; SYSTEMIC CIRCULATION; ZETA POTENTIAL;

BIODISTRIBUTION; CHITOSAN; IMAGING; LYMPH NODE; NANOCARRIER; NANOVACCINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; GLUCOSAMINE; LYMPH NODES; LYMPHOSCINTIGRAPHY; MALE; NANOCAPSULES; POLYSACCHARIDES; RABBITS; TISSUE DISTRIBUTION;

EID: 84895885680     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.059     Document Type: Article

References (22)

1. Duncan R., Gaspar R. Nanomedicine(s) under the microscope. Mol Pharmaceutics 2011, 8(6):2101-2141.
2. Vicente S., Prego C., Csaba N., Alonso M.J. From single-dose vaccine delivery systems to nanovaccines. J Drug Delivery Sci Technol 2010, 20(4):267-276.
3. Peek L.J., Middaugh C.R., Berkland C. Nanotechnology in vaccine delivery. Adv Drug Delivery Rev 2008, 60:915-928.
4. Bachmann M.F., Jennings G.T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010, 10(11):787-796.
5. Moon J.J., Huang B., Irvine D.J. Engineering nano- and microparticles to tune immunity. Adv Mater 2012, 24(28):3724-3746.
6. Csaba N., Garcia-Fuentes M., Alonso M.J. Nanoparticles for nasal vaccination. Adv Drug Delivery Rev 2009, 61(2):140-157.
7. Oyarzun-Ampuero F.A., Garcia-Fuentes M., Torres D., Alonso M.J. Chitosan-coated lipid nanocarriers for therapeutic applications. J Drug Delivery Sci Technol 2010, 20(4):259-265.
8. Vicente S., Díaz B., Peleteiro M., Sanchez A., Pascual D.W., González-Fernández A., et al. A polymer/oil based nanovaccine as a single-dose immunization approach. PLoS One 2013, 8(4):e62500.
9. Vicente S, Peleteiro M, Gonzalez-Aramundiz JV, Diaz-Freitas B, Martinez-Pulgarin S, Neissa JI, et al. Highly versatile immunostimulating nanocapsules for specific immune potentiation, Nanomedicine (Lond), 2014, in press.
10. De Temmerman M., Rejman J., Demeester J., Irvine D.J., Gander B., De Smedt S.C. Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discovery Today 2011, 16(13-14):569-582.
11. Phillips W., Rudolph A., Goins B., Timmons J., Klipper R., Blumhardt R. A simple method for producing a Tc-99m-labeled liposome which is stable in vivo. Nucl Med Biol 1992, 19(5):539.
12. Maruyama K., Kennel S., Huang L. Lipid-composition is important for highly efficient target binding and retention of immunoliposomes. PNAS 1990, 87(15):5744-5748.
13. Pereira M.A., Mosqueira V.C.F., Vilela J.M.C., Andrade M.S., Ramaldes G.A., Cardoso V.N. PLA-PEG nanocapsules radiolabeled with 99mTechnetium-HMPAO: release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy. Eur J Pharm Sci 2008, 33(1):42-51.
14. Chinol M., Vallabhajosula S., Goldsmith S.J., Paganelli G., Palestro C.J. Evaluation of four radiopharmaceuticals for imaging inflammation in a rabbit model of arthritis. Ann Nucl Med 1996, 10(3):287-291.
15. Phillips W.T., Andrews T., Liu H., Klipper R., Landry A.J., Blumhardt R., et al. Evaluation of [(99m)Tc] liposomes as lymphoscintigraphic agents: comparison with [(99m)Tc] sulfur colloid and [(99m)Tc] human serum albumin. Nucl Med Biol 2001, 28(4):435-444.
16. Cubas R., Zhang S., Kwon S., Sevick-Muraca E.M., Li M., Chen C., Yao Q. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother 2009, 32(2):118-128.
17. Helbok A., Decristoforo C., Dobrozemsky G., Rangger C., Diederen E., Stark B., et al. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals. J Liposome Res 2010, 20(3):219-227.
18. Mougin-Degraef M., Bourdeau C., Jestin E., Sai-Maurel C., Bourgeois A., Remaud-Le Saec P., et al. Doubly radiolabeled liposomes for pretargeted radioimmunotherapy. Int J Pharm 2007, 344(1-2):110-117.
19. Oussoren C., Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Delivery Rev 2001, 50(1-2):143-156.
20. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. J Immunol 2008, 38:1404-1413.
21. Bourquin C., Anz D., Zwiorek K., Lanz A., Fuchs S., Weigel S., et al. Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity. J Immunol 2008, 181(5):2990-2998.
22. Anderson C., Welch M. Radiometal labeled agents (non-technetium) for diagnostic imaging. Chem Rev 1999, 99(9):2219-2234.